Chihiro Morishima

Associate Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Chihiro Morishima is an Associate Professor at the University of Washington, USA. Their research focuses on data analytics in medical diagnostics, immunological responses to vaccines, and the implications of copper deficiency in liver disease. Recent articles highlight their work on the accuracy of serum free light chain results, immune responses to SARS-CoV-2 vaccines, and the performance characteristics of various antibody assays.

Articles (9)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Susan L Fink

University of Washington

UNITED STATES

View details

Lauren Rodda

Assistant Professor

Oregon Health & Science University

UNITED STATES

View details

Anu Chaudhary

University of Washington

UNITED STATES

View details

Andrew Bryan

University of Washington

UNITED STATES

View details

STEPHEN RAWLINGS

Assistant Professor of Medicine

Maine Medical Center

UNITED STATES

View details

Anna Wald

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chihiro Morishima

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy

Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies

Copper deficiency is an independent risk factor for mortality in patients with advanced liver disease

T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity

Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine–Induced Immune Responses in Multiple Sclerosis Patients

Anti-Nuclear Antibody Quantitation: Calibration and Harmonization Adjustment via Population Interrogation

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.

Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results.

Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.

Collaborators (6)

Susan L Fink

Lauren Rodda

Anu Chaudhary

Andrew Bryan

STEPHEN RAWLINGS

Anna Wald

Make your next move.